MXPA04001679A - Sistema terapeutico transdermico (tt) con fentanilo como el ingrediente activo. - Google Patents
Sistema terapeutico transdermico (tt) con fentanilo como el ingrediente activo.Info
- Publication number
- MXPA04001679A MXPA04001679A MXPA04001679A MXPA04001679A MXPA04001679A MX PA04001679 A MXPA04001679 A MX PA04001679A MX PA04001679 A MXPA04001679 A MX PA04001679A MX PA04001679 A MXPA04001679 A MX PA04001679A MX PA04001679 A MXPA04001679 A MX PA04001679A
- Authority
- MX
- Mexico
- Prior art keywords
- active ingredient
- fentanyl
- transdermal therapeutic
- tts
- therapeutic system
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7038—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer
- A61K9/7046—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds
- A61K9/7069—Transdermal patches of the drug-in-adhesive type, i.e. comprising drug in the skin-adhesive layer the adhesive comprising macromolecular compounds obtained otherwise than by reactions only involving carbon to carbon unsaturated bonds, e.g. polysiloxane, polyesters, polyurethane, polyethylene oxide
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
- A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
- A61K9/7092—Transdermal patches having multiple drug layers or reservoirs, e.g. for obtaining a specific release pattern, or for combining different drugs
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dermatology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical & Material Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Pain & Pain Management (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Biomedical Technology (AREA)
- Rheumatology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Hydrogenated Pyridines (AREA)
Abstract
La invencion describe sistemas terapeuticos transdermicos con fentanilo o un derivado de fentanilo analogo como el ingrediente activo; a fin de prevenir una sobredosis inadvertida a traves de la liberacion no controlada de ingrediente activo como un resultado de un dano, el ingrediente activo esta contenido en microdepositos llenados con fluidos en la capa que contiene el ingrediente activo; la capa que contiene el ingrediente activo opcionalmente sustituido puede estar provista con una membrana.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DE10141651A DE10141651B4 (de) | 2001-08-24 | 2001-08-24 | Transdermales Therapeutisches System (TTS) mit dem Wirkstoff Fentanyl und Verfahren zu seiner Herstellung |
PCT/EP2002/007663 WO2003018071A1 (de) | 2001-08-24 | 2002-07-10 | Transdermales therapeutisches system (tts) mit dem wirkstoff fentanyl |
Publications (1)
Publication Number | Publication Date |
---|---|
MXPA04001679A true MXPA04001679A (es) | 2004-05-31 |
Family
ID=7696569
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
MXPA04001679A MXPA04001679A (es) | 2001-08-24 | 2002-07-10 | Sistema terapeutico transdermico (tt) con fentanilo como el ingrediente activo. |
Country Status (24)
Country | Link |
---|---|
US (2) | US7390500B2 (es) |
EP (1) | EP1418951B1 (es) |
JP (1) | JP4628673B2 (es) |
KR (1) | KR100895188B1 (es) |
CN (1) | CN100438859C (es) |
AT (1) | ATE455541T1 (es) |
AU (1) | AU2002321199B2 (es) |
BR (1) | BRPI0212028B8 (es) |
CA (1) | CA2457245C (es) |
CY (1) | CY1109954T1 (es) |
DE (2) | DE10141651B4 (es) |
DK (1) | DK1418951T3 (es) |
ES (1) | ES2339640T3 (es) |
HK (1) | HK1069534A1 (es) |
HU (1) | HU229942B1 (es) |
IL (2) | IL160515A0 (es) |
MX (1) | MXPA04001679A (es) |
NZ (1) | NZ530795A (es) |
PL (1) | PL204348B1 (es) |
PT (1) | PT1418951E (es) |
RU (1) | RU2311908C2 (es) |
TW (1) | TW570815B (es) |
WO (1) | WO2003018071A1 (es) |
ZA (1) | ZA200400473B (es) |
Families Citing this family (28)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE10141650C1 (de) * | 2001-08-24 | 2002-11-28 | Lohmann Therapie Syst Lts | Transdermales Therapeutisches System mit Fentanyl bzw. verwandten Substanzen |
US20040086551A1 (en) | 2002-10-30 | 2004-05-06 | Miller Kenneth J. | Fentanyl suspension-based silicone adhesive formulations and devices for transdermal delivery of fentanyl |
BRPI0407323A (pt) * | 2003-02-07 | 2006-02-21 | Lohmann Therapie Syst Lts | sistema terapêutico transdermal apropriado para uso térmico para acelarar a permeação de substáncias ativas e uso do mesmo |
WO2004089361A1 (en) * | 2003-04-14 | 2004-10-21 | Lts Lohmann Therapie-Systeme Ag | Therapeutic patch with polysiloxane matrix comprising capsaicin |
US20110086086A1 (en) * | 2005-07-26 | 2011-04-14 | Pfizer Inc | Transdermal system for varenicline |
DE102006019293A1 (de) * | 2006-04-21 | 2007-10-25 | LABTEC Gesellschaft für technologische Forschung und Entwicklung mbH | Pflaster, enthaltend ein Fentanyl Analogum |
GB0615429D0 (en) * | 2006-08-03 | 2006-09-13 | Chowdhury Dewan F H | Transdermal drug delivery with temporal control |
DE102006054731B4 (de) | 2006-11-21 | 2013-02-28 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System zur Verabreichung des Wirkstoffs Buprenorphin und Verwendung desselben in der Schmerztherapie |
DE102006054732B4 (de) * | 2006-11-21 | 2010-12-30 | Lts Lohmann Therapie-Systeme Ag | Transdermales therapeutisches System mit Ionenpaar-Mikroreservoiren |
DE102008016804B4 (de) * | 2008-04-02 | 2012-01-05 | Lts Lohmann Therapie-Systeme Ag | Selbstzerstörendes transdermales therapeutisches System mit verbesserter Funktionalität und Wirksamkeit sowie seine Verwendung |
US20100221313A1 (en) * | 2008-12-01 | 2010-09-02 | Innovative Pharmaceuticals, Llc | Transdermal reservoir patch |
CN102597149A (zh) * | 2009-07-21 | 2012-07-18 | 迈兰公司 | 用于连续制造聚异丁烯基透皮贴剂的工艺 |
US9822088B2 (en) | 2011-03-30 | 2017-11-21 | The United States Of America As Represented By The Administrator Of Nasa | Anisotropic copoly(imide oxetane) coatings and articles of manufacture, copoly(imide oxetane)s containing pendant fluorocarbon moieties, oligomers and processes therefor |
DE102011080390B3 (de) * | 2011-08-03 | 2012-07-12 | Acino Ag | Applikationshilfe |
SG11201403162XA (en) | 2011-12-12 | 2014-10-30 | Lohmann Therapie Syst Lts | Transdermal delivery system comprising buprenorphine |
TW201431570A (zh) * | 2012-11-22 | 2014-08-16 | Ucb Pharma Gmbh | 用於經皮投服羅替戈汀(Rotigotine)之多天式貼片 |
TN2015000493A1 (en) * | 2013-06-04 | 2017-04-06 | Lts Lohmann Therapie Systeme Ag | Transdermal delivery system |
CN105358139B (zh) | 2013-07-03 | 2020-10-16 | Lts罗曼治疗方法有限公司 | 具有电子元件的经皮治疗系统 |
CN106456566B (zh) | 2014-05-20 | 2020-06-16 | Lts勒曼治疗系统股份公司 | 含罗替戈汀的经皮递送系统 |
CA2948219C (en) | 2014-05-20 | 2023-04-04 | Lts Lohmann Therapie-Systeme Ag | Method for adjusting the release of active agent in a transdermal delivery system |
EP4238580A3 (en) | 2014-05-20 | 2023-10-25 | LTS Lohmann Therapie-Systeme AG | Transdermal delivery system including an interface mediator |
US9962340B2 (en) | 2015-06-09 | 2018-05-08 | Life Tech Global, Llc | Device and method for the transdermal delivery of cannabidiol |
US10272125B2 (en) * | 2015-09-14 | 2019-04-30 | Life Tech Global, Llc | Transdermal delivery of cannabidiol with other active moieties including cannabinoids |
US9650338B1 (en) | 2016-07-29 | 2017-05-16 | VDM Biochemicals, Inc. | Opioid antagonist compounds and methods of making and using |
DE102017107468B4 (de) * | 2017-04-06 | 2019-02-21 | Lts Lohmann Therapie-Systeme Ag | Verfahren zur herstellung eines, insbesondere oralen, wirkstofflaminats und wirkstofflaminat, insbesondere orales wirkstofflaminat |
AU2018254418B2 (en) | 2017-04-18 | 2023-04-13 | Breakthrough Technologies, LLC | Sulfur production |
BR112020003314A2 (pt) * | 2017-09-04 | 2020-08-25 | Lts Lohmann Therapie-Systeme Ag | sistema de liberação transdérmico incluindo um emulsificante |
JP6912122B2 (ja) * | 2019-02-28 | 2021-07-28 | 日本臓器製薬株式会社 | 経皮投与製剤 |
Family Cites Families (24)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5310559A (en) * | 1982-09-01 | 1994-05-10 | Hercon Laboratories Corporation | Device for controlled release and delivery to mammalian tissue of pharmacologically active agents incorporating a rate controlling member which comprises an alkylene-alkyl acrylate copolymer |
US4588580B2 (en) * | 1984-07-23 | 1999-02-16 | Alaz Corp | Transdermal administration of fentanyl and device therefor |
US4645502A (en) * | 1985-05-03 | 1987-02-24 | Alza Corporation | Transdermal delivery of highly ionized fat insoluble drugs |
US6110488A (en) * | 1986-08-28 | 2000-08-29 | Lts Lohmann Therapie-Systeme Gmbh & Co. Kg | Transdermal therapeutic system, its use and production process |
US4906463A (en) * | 1986-12-22 | 1990-03-06 | Cygnus Research Corporation | Transdermal drug-delivery composition |
US4822802A (en) * | 1987-02-24 | 1989-04-18 | Alza Corporation | Method of fentanly administration for postoperative pain relief |
US4849224A (en) * | 1987-11-12 | 1989-07-18 | Theratech Inc. | Device for administering an active agent to the skin or mucosa |
FR2623718B1 (fr) * | 1987-11-27 | 1994-04-15 | Fabre Medicament Pierre | Dispositif therapeutique transdermique et son procede de preparation |
US5656286A (en) * | 1988-03-04 | 1997-08-12 | Noven Pharmaceuticals, Inc. | Solubility parameter based drug delivery system and method for altering drug saturation concentration |
DE3905051A1 (de) * | 1989-02-18 | 1990-08-30 | Lohmann Therapie Syst Lts | Therapeutisches system zur verzoegerten und gesteuerten transdermalen oder transmucosalen verabreichung von wirkstoffen (i) |
DE3910543A1 (de) * | 1989-04-01 | 1990-10-11 | Lohmann Therapie Syst Lts | Transdermales therapeutisches system mit erhoehtem wirkstofffluss und verfahren zu seiner herstellung |
SE8904296D0 (sv) * | 1989-12-21 | 1989-12-21 | Pharmacia Ab | Transdermal system |
JP3202777B2 (ja) * | 1992-01-24 | 2001-08-27 | リンテック株式会社 | 経皮吸収促進剤及びテープ製剤 |
ES2164286T3 (es) * | 1993-04-20 | 2002-02-16 | Hexal Ag | Emplasto con sustancias activas. |
CN1094972A (zh) * | 1993-05-21 | 1994-11-16 | 深圳广信生物工程公司 | 控释透皮治疗系统及其制备与应用 |
JP3240496B2 (ja) * | 1993-09-30 | 2001-12-17 | タキロン株式会社 | 経皮吸収製剤 |
US5665378A (en) * | 1994-09-30 | 1997-09-09 | Davis; Roosevelt | Transdermal therapeutic formulation |
JP4346696B2 (ja) * | 1996-05-28 | 2009-10-21 | 久光製薬株式会社 | 経皮治療用装置 |
DE19728517C2 (de) * | 1997-07-04 | 1999-11-11 | Sanol Arznei Schwarz Gmbh | TTS zur Verabreichung von Sexualsteroidhormonen und Verfahren zu seiner Herstellung |
KR19980025307A (ko) * | 1998-04-11 | 1998-07-06 | 조태임 | 진통효과를 갖는 약물의 경피흡수제제 |
US6312715B1 (en) * | 1998-05-01 | 2001-11-06 | 3M Innovative Properties Company | Adhesive microsphere drug delivery composition |
ES2194736T3 (es) * | 1999-07-02 | 2003-12-01 | Lohmann Therapie Syst Lts | Sistema de microdepositos sobre la base de polisiloxanos y disolvente ambifilos. |
DE19958554C2 (de) * | 1999-07-02 | 2002-06-13 | Lohmann Therapie Syst Lts | Mikroreservoirsystem auf Basis von Polysiloxanen und ambiphilen Lösemitteln und ihre Herstellung |
US6893655B2 (en) * | 2001-10-09 | 2005-05-17 | 3M Innovative Properties Co. | Transdermal delivery devices |
-
2001
- 2001-08-24 DE DE10141651A patent/DE10141651B4/de not_active Expired - Lifetime
-
2002
- 2002-07-10 HU HU0401512A patent/HU229942B1/hu unknown
- 2002-07-10 PT PT02754860T patent/PT1418951E/pt unknown
- 2002-07-10 CA CA2457245A patent/CA2457245C/en not_active Expired - Lifetime
- 2002-07-10 MX MXPA04001679A patent/MXPA04001679A/es active IP Right Grant
- 2002-07-10 KR KR1020047002709A patent/KR100895188B1/ko active IP Right Grant
- 2002-07-10 ES ES02754860T patent/ES2339640T3/es not_active Expired - Lifetime
- 2002-07-10 EP EP02754860A patent/EP1418951B1/de not_active Expired - Lifetime
- 2002-07-10 NZ NZ530795A patent/NZ530795A/en not_active IP Right Cessation
- 2002-07-10 DE DE50214184T patent/DE50214184D1/de not_active Expired - Lifetime
- 2002-07-10 AT AT02754860T patent/ATE455541T1/de active
- 2002-07-10 IL IL16051502A patent/IL160515A0/xx unknown
- 2002-07-10 AU AU2002321199A patent/AU2002321199B2/en not_active Expired
- 2002-07-10 CN CNB02816427XA patent/CN100438859C/zh not_active Expired - Lifetime
- 2002-07-10 WO PCT/EP2002/007663 patent/WO2003018071A1/de active IP Right Grant
- 2002-07-10 BR BR0212028-3 patent/BRPI0212028B8/pt not_active IP Right Cessation
- 2002-07-10 RU RU2004108849/15A patent/RU2311908C2/ru active
- 2002-07-10 DK DK02754860.1T patent/DK1418951T3/da active
- 2002-07-10 PL PL366857A patent/PL204348B1/pl unknown
- 2002-07-10 US US10/487,375 patent/US7390500B2/en not_active Expired - Lifetime
- 2002-07-10 JP JP2003522586A patent/JP4628673B2/ja not_active Expired - Lifetime
- 2002-08-22 TW TW091119026A patent/TW570815B/zh not_active IP Right Cessation
-
2004
- 2004-01-22 ZA ZA200400473A patent/ZA200400473B/en unknown
- 2004-02-23 IL IL160515A patent/IL160515A/en active IP Right Grant
-
2005
- 2005-03-11 HK HK05102132.0A patent/HK1069534A1/xx not_active IP Right Cessation
-
2008
- 2008-05-07 US US12/116,303 patent/US20080274167A1/en not_active Abandoned
-
2010
- 2010-03-29 CY CY20101100289T patent/CY1109954T1/el unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
IL160515A0 (en) | Transdermal therapeutic system (tts) with fentanyl as active ingredient | |
AU2002321199A1 (en) | Transdermal therapeutic system (TTS) with fentanyl as active ingredient | |
DE60129849D1 (de) | Bioadhäsiver schaumstoffilm mit hinhaltender wirkstoffreigabe | |
ATE342097T1 (de) | Elektroaktive pore | |
ES2176234T3 (es) | Sistema terapeutico transdermal con galantamina como componente activo. | |
ES2164780T3 (es) | Dispositivo transdermico mejorado con desestratificacion reducida. | |
WO2001068060A3 (de) | Stabilisierte übersättigte transdermale therapeutische matrixsysteme | |
MXPA04001676A (es) | Sistema terapeutico transdermico con fentanilo o sustancias relacionadas. | |
NZ541807A (en) | UV stable transdermal therapeutic plaster | |
ATE396714T1 (de) | Transdermales therapeutisches system mit verbessertem langzeittragekomfort | |
HUP0204448A2 (en) | Trnasdermal therapeutic system for the delivery of lerisetron | |
ATE293442T1 (de) | Desoxypeganin-tts | |
WO2001026637A3 (de) | Transdermales therapeutisches system zur abgabe von acetylsalicylsäure und/oder salicylsäure | |
DK1143938T3 (da) | Transdermalt terapeutisk system med en selvklæbende matrix, der indeholder organiske syreadditionssalte af alkaloider af morphin- eller morphin-type | |
WO2002017928A3 (de) | Transdermales therapeutisches system zur abgabe von exemestan | |
DE59910944D1 (de) | Transdermales therapeutisches system zur anwendung von candesartan | |
ATE340567T1 (de) | Transdermales therapeutisches system zur verabreichung des partiellen dopamin-d2-agonisten aripiprazol | |
WO2001003678A3 (de) | Transdermales therapeutisches system zur anwendung von tolterodin | |
MY131858A (en) | Active ingredient combination for the pharmacological therapy of nicotine dependence | |
WO2003026555A3 (en) | Floating osmotic device for controlled release drug delivery | |
AR037405A1 (es) | Sistema terapeutico transdermal para la administracion de 17alfa-estradiol |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FG | Grant or registration |